$GALT GALECTIN THERAPEUTICS INC Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in GALECTIN THERAPEUTICS INC.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview


Overview of insider trading in GALECTIN THERAPEUTICS INC. Insider overview, share value development, latest insider transactions and email notifications about new events in GALECTIN THERAPEUTICS INC for free.

CIK Number: 0001133416
IRS Number: 043562325
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: GALT
Company Address: 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS 30071
Phone number: 678-620-3186
Former name: PRO PHARMACEUTICALS INC, date of change: 2001-06-12

Galectin Therapeutics, Inc. is a biotechnology company, which engages in drug research and development to create new therapies for fibrotic disease, severe skin disease, and cancer. Its programs target the development of carbohydrate molecules which offers alternative options to larger market segments. The company was founded by James C. Czirr and Anatole A. Klyosov on July 10, 2000 and is headquartered in Norcross, GA.

Market Capitalization: $34.39M
Prev close: $1.27
Average Daily Volume: 361,044
Days Low: $1.15
Year Low: $0.49
Year High: $3.05

GALECTIN THERAPEUTICS INC Latest Insider Transactions

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
May 04 2021GALTGALECTIN THERAPEUT ...10X Fund, L.P.10% OwnerSellS3.8410,00038,4006,288,9406.3 M to 6.3 M (-0.16 %)
May 04 2021GALTGALECTIN THERAPEUT ...10X Fund, L.P.10% OwnerSellS4.477,50033,5256,298,9406.3 M to 6.3 M (-0.12 %)
May 04 2021GALTGALECTIN THERAPEUT ...10X Fund, L.P.10% OwnerSellS3.955,00019,7506,306,4406.3 M to 6.3 M (-0.08 %)
May 04 2021GALTGALECTIN THERAPEUT ...10X Fund, L.P.10% OwnerSellS3.525,00017,6006,311,4406.3 M to 6.3 M (-0.08 %)
May 04 2021GALTGALECTIN THERAPEUT ...10X Fund, L.P.10% OwnerSellS3.8410,00038,4006,288,9406.3 M to 6.3 M (-0.16 %)
May 04 2021GALTGALECTIN THERAPEUT ...10X Fund, L.P.10% OwnerSellS4.477,50033,5256,298,9406.3 M to 6.3 M (-0.12 %)
May 04 2021GALTGALECTIN THERAPEUT ...10X Fund, L.P.10% OwnerSellS3.955,00019,7506,306,4406.3 M to 6.3 M (-0.08 %)
May 04 2021GALTGALECTIN THERAPEUT ...10X Fund, L.P.10% OwnerSellS3.525,00017,6006,311,4406.3 M to 6.3 M (-0.08 %)
May 03 2021GALTGALECTIN THERAPEUT ...LEWIS JOELPresident and CEOGrantA4.423,77116,668213,249209.5 K to 213.2 K (+1.80 %)
Apr 19 2021GALTGALECTIN THERAPEUT ...Uihlein Richard EDirectorOption ExerciseA5.002,000,00010,000,00010,000,000
Apr 16 2021GALTGALECTIN THERAPEUT ...LEWIS JOELPresident and CEOGrantA2.237,47416,667209,478202 K to 209.5 K (+3.70 %)
Apr 06 2021GALTGALECTIN THERAPEUT ...FREEMAN KEVIN DDirectorBuyP2.045,00010,20030,00025 K to 30 K (+20.00 %)
Mar 31 2021GALTGALECTIN THERAPEUT ...LEWIS JOELPresident and CEOGrantA2.177,68016,666202,004194.3 K to 202 K (+3.95 %)
Mar 31 2021GALTGALECTIN THERAPEUT ...Schwartz Elissa J.DirectorOption ExerciseA2.1170,000147,70070,000
Mar 31 2021GALTGALECTIN THERAPEUT ...Schwartz Elissa J.DirectorOption ExerciseA2.1140,00084,40040,000

View all GALECTIN THERAPEUTICS INC insider transactions.